You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石四藥集團(02005.HK)取得中國國家藥品監督管理局有關伏立康唑乾混懸劑(45g:3g)的藥品生產註冊批件
格隆匯 03-21 16:35

石四藥集團(02005.HK)公吿,集團已取得中國國家藥品監督管理局有關伏立康唑乾混懸劑(45g:3g)的藥品生產註冊批件,屬於化學藥品第4類,視同通過一致性評價。

伏立康唑乾混懸劑屬口服混懸劑型,可用於兩歲或以上兒童及成年患者,主要用於治療各類真菌感染,包括侵襲性麴黴病、念珠菌血症及念珠菌、足放線病菌屬和鐮刀菌屬引起的嚴重感染,以及用於預防接受異基因造血幹細胞移植(HSCT)的高危患者的侵襲性真菌感染。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account